Check out your Company Bowl for anonymous work chats.
The year 1990 marked a turning point in Sartorius' corporate history: The company, which had been family-run until then, went public. Along with a new strategic focus on life science research and the biopharmaceutical industry, this pointed the way to the future – and ultimately led to a sustained positive development.
Sartorius is expanding its production facilities in Ajdovscina, Slovenia: The area for manufacturing and labs will increase from 3,000 square meters to 6,200 square meters. Today’s ribbon cutting was attended by the Prime Minister of the Republic of Slovenia, Janez Janša. Read more: https://bit.ly/3fPIStH
How can companies solve complex scientific problems in today’s #lifescience and #biotechnology industry? For our Head of Corporate Research, Oscar-Werner Reif, the answer is clear: By fostering #partnership and #collaboration with leading experts. In this interview, he explains how Sartorius is driving #innovation - together with customers, universities, start-ups, companies, or in initiatives like NIIMBL | The National Institute for Innovation in Manufacturing Biopharmaceuticals. Learn more about Sartorius’ collaborative approach: http://ow.ly/oeow50ERdjI
At Sartorius, innovative solutions for our customers are created as a team: For example, when long-standing employees combine their experience with the fresh ideas of new colleagues — a healthy mix of "old hands" and newcomers makes this possible. Find out more about #diversity at Sartorius: https://bit.ly/3tRCnvD
At Sartorius, #diversity is about #culture. We are convinced that it is only when we are open towards all people and new perspectives that can we create innovative ideas and be successful. This is why we foster diversity at all levels within our organization. For example, even as a global company, Sartorius is still becoming more international every year: Today, more than 11,000 people from nearly 100 nations team up at our company to find creative ways that simplify the work of our customers.
After leading a high-performing R&D team at Sartorius for many years, Magali Barbaroux reached a turning point in her career and had to choose whether she wanted to further pursue a management career or become a research fellow. She decided to go for her dream job.
“It doesn’t matter if you are a man or a woman as long as you continue to improve,” states Abby Gao, Key Account Manager for Sartorius in Shanghai. Read more on how she is living her childhood dream by supporting vaccine production today.
Generating scientific and technological expertise and transforming it into industrial products are of crucial importance for Sartorius. To understand how Sartorius drives #innovation, we have initiated a series of interviews with Dr. Oscar-Werner Reif, Head of Corporate Research and Chief Technology Officer. In this first interview, he explains the role of his department, the latest trends his team is working on and how ideas are transformed into products.
Sartorius with first-quarter uptick in sales and earnings: The life science group Sartorius had an exceptionally strong start in fiscal 2021 and grew substantially in order intake, sales revenue and earnings.
Sartorius is strengthening its footprint in China. Today, we opened a new 7,500-square-foot Customer Interaction Center (CIC) in Beijing. The CIC will enable our Chinese customers to test, validate, and adjust the functionalities of equipment, prior to installation at their factories.
